Press Releases

HITRUST Implemented, 1-Year Certification validates Omnicell‘s commitment to managing cybersecurity risk and protecting sensitive information

Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will present at the Piper Sandler 35 th Annual Healthcare Conference on Tuesday, November 28, 2023 at 1:00...

Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the third quarter 2023, before market open on Thursday, November 2,...

Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the third quarter 2023, before market open on Thursday, November 2,...

Total GAAP revenues of $299 million GAAP net income per diluted share of $0.12 Non-GAAP net income per diluted share of $0.62 Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leader in transforming the...

Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the third quarter 2023, before market open on Thursday, November 2,...

Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, announced that it will present at the 2023 Wells Fargo Healthcare Conference on Wednesday, September 6, 2023 at 3:00 p.m. ET. Live and archived webcasts of the...

Total GAAP revenues of $299 million GAAP net income per diluted share of $0.08 Non-GAAP net income per diluted share of $0.57 Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leader in transforming the...

Total GAAP revenues of $299 million GAAP net income per diluted share of $0.08 Non-GAAP net income per diluted share of $0.57 Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leader in transforming the...

Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the second quarter 2023, after market close on Tuesday, August 1,...

Established Leader Brings Global SaaS and Healthcare Technology Experience to Board Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced it has increased its number of...

Omnicell, Inc. (Nasdaq: OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced changes to its leadership structure designed to create a more streamlined organization with a continued focus on...

Seasoned Leader Brings Over Two Decades of Finance and Accounting Experience to Omnicell Omnicell, Inc. (Nasdaq: OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy care delivery model, today announced that Nchacha E. Etta has...

Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy care delivery model, announced that it will present at the BofA Securities 2023 Healthcare Conference on Thursday, May 11, 2023 at 8:00 a.m. PT. Live...

Total GAAP revenues of $291 million GAAP net loss per diluted share of $0.33 Non-GAAP net income per diluted share of $0.39 Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leader in transforming the...

Total GAAP revenues of $291 million GAAP net loss per diluted share of $0.33 Non-GAAP net income per diluted share of $0.39 Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell,” “we,” “our,” “us,” “management,” or the “Company”), a leader in transforming the...